Standard BioTools Long Term Debt 2012-2026 | LAB
Standard BioTools long term debt from 2012 to 2026. Long term debt can be defined as the sum of all long term debt fields.
|
Standard BioTools Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2025 | $0 |
| 2024 | $0 |
| 2023 | $4 |
| 2022 | $63 |
| 2021 | $64 |
| 2020 | $54 |
| 2019 | $54 |
| 2018 | $172 |
| 2017 | $195 |
| 2016 | $195 |
| 2015 | $195 |
| 2014 | $195 |
| 2013 | |
| 2012 | |
| 2011 | $1 |
|
Standard BioTools Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2026-03-31 | $0 |
| 2025-12-31 | $0 |
| 2025-09-30 | $0 |
| 2025-06-30 | $0 |
| 2025-03-31 | $0 |
| 2024-12-31 | $0 |
| 2024-09-30 | $0 |
| 2024-06-30 | $0 |
| 2024-03-31 | $0 |
| 2023-12-31 | $4 |
| 2023-09-30 | $60 |
| 2023-06-30 | $61 |
| 2023-03-31 | $62 |
| 2022-12-31 | $63 |
| 2022-09-30 | $64 |
| 2022-06-30 | $65 |
| 2022-03-31 | $100 |
| 2021-12-31 | $64 |
| 2021-09-30 | $64 |
| 2021-06-30 | $54 |
| 2021-03-31 | $54 |
| 2020-12-31 | $54 |
| 2020-09-30 | $54 |
| 2020-06-30 | $54 |
| 2020-03-31 | $54 |
| 2019-12-31 | $54 |
| 2019-09-30 | $50 |
| 2019-06-30 | $50 |
| 2019-03-31 | $50 |
| 2018-12-31 | $172 |
| 2018-09-30 | $169 |
| 2018-06-30 | $167 |
| 2018-03-31 | $164 |
| 2017-12-31 | $195 |
| 2017-09-30 | $195 |
| 2017-06-30 | $195 |
| 2017-03-31 | $195 |
| 2016-12-31 | $195 |
| 2016-09-30 | $195 |
| 2016-06-30 | $195 |
| 2016-03-31 | $195 |
| 2015-12-31 | $195 |
| 2015-09-30 | $196 |
| 2015-06-30 | $196 |
| 2015-03-31 | $196 |
| 2014-12-31 | $195 |
| 2014-09-30 | $195 |
| 2014-06-30 | $195 |
| 2014-03-31 | $195 |
| 2013-12-31 | |
| 2013-09-30 | |
| 2013-06-30 | |
| 2013-03-31 | |
| 2012-12-31 | |
| 2012-09-30 | |
| 2012-06-30 | |
| 2012-03-31 | |
| 2011-12-31 | $1 |
| 2011-09-30 | $3 |
| 2011-06-30 | $5 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.345B | $0.085B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $24.733B | 27.19 |
| Tempus AI (TEM) | United States | $7.677B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $4.429B | 38.86 |
| Doximity (DOCS) | United States | $3.888B | 16.84 |
| IRhythm Holdings (IRTC) | United States | $3.724B | 0.00 |
| 10x Genomics (TXG) | United States | $2.973B | 0.00 |
| Privia Health (PRVA) | United States | $2.810B | 131.59 |
| Hinge Health (HNGE) | United States | $2.789B | 0.00 |
| Heartflow (HTFL) | United States | $2.311B | 0.00 |
| Omnicell (OMCL) | United States | $1.564B | 43.00 |
| Inspire Medical Systems (INSP) | United States | $1.555B | 20.94 |
| Enovis (ENOV) | United States | $1.405B | 7.40 |
| Butterfly Network (BFLY) | United States | $1.047B | 0.00 |
| Azenta (AZTA) | United States | $1.023B | 41.13 |
| Clover Health Investments (CLOV) | United States | $1.013B | 0.00 |
| Talkspace (TALK) | United States | $0.864B | 103.40 |
| Schrodinger (SDGR) | United States | $0.839B | 0.00 |
| Phreesia (PHR) | United States | $0.490B | 50.38 |
| Fulgent Genetics (FLGT) | United States | $0.429B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.322B | 0.00 |
| CapsoVision (CV) | United States | $0.311B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.279B | 0.00 |
| Claritev (CTEV) | United States | $0.269B | 0.00 |
| TruBridge (TBRG) | United States | $0.268B | 8.60 |
| Evolent Health (EVH) | United States | $0.260B | 0.00 |
| Carlsmed (CARL) | United States | $0.239B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.196B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.189B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 8.18 |
| Nyxoah SA (NYXH) | Belgium | $0.111B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.102B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.101B | 0.00 |
| American Well (AMWL) | United States | $0.086B | 0.00 |
| Outset Medical (OM) | United States | $0.077B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.073B | 0.00 |
| Pulmonx (LUNG) | United States | $0.058B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.049B | 0.00 |
| HeartBeam (BEAT) | United States | $0.047B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.034B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.018B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.009B | 0.00 |
| Zhongchao (ZCMD) | China | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |